Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      LOTTE BIOLOGICS slávnostne začína výstavbu areálu Songdo Bio Campus

      LOTTE BIOLOGICS' Corporate Identity(CI)

      News provided by

      LOTTE BIOLOGICS

      Jul 05, 2024, 10:26 ET

      Share this article

      Share this article


      • Spoločnosť sa plánuje zaradiť medzi 10 najväčších globálnych výrobcov CDMO, čo predznamenáva novú éru v sektore.

      SOUL, Južná Kórea, 4. júla 2024 /PRNewswire/ – Na významnom podujatí, ktoré signalizuje ambiciózny vstup do biofarmaceutického sektora spoločnosť LOTTE BIOLOGICCS pod vedením generálneho riaditeľa Richarda W. Leeho 3. júla slávnostne položila základy svojho inauguračného závodu v Songdo Bio Campus v Incheon International City. Slávnostná ceremónia, ktorá sa začala o 11:00, znamenala kľúčový moment na ceste spoločnosti medzi top 10 organizácií pre zmluvný vývoj a výrobu (CDMO) na svete.

      Continue Reading
      Groundbreaking ceremony participants taking part in the ceremonial first dig l (from left: LOTTE BIOLOGICS Chief Global Strategy Officer Yoo-Yeol Shin, Incheon Yeonsu District Mayor Jae-Ho Lee, LOTTE E&C CEO Hyeon-Cheol Park, LOTTE Corporation CEO Dong-Woo Lee, National Assembly Member Il-Young Jung, LOTTE Chairman Dong-Bin Shin, Incheon Mayor Jeong-Bok Yoo, First Vice Minister of Trade, Industry and Energy Kyung-Sung Kang, Second Vice Minister of Health and Welfare Min-Soo Park, LOTTE BIOLOGICS CEO Richard W. Lee, Incheon Free Economic Zone Commissioner Won-Seok Yoon, and LOTTE Holdings Japan CEO Genichi Tamatsuka)
      Groundbreaking ceremony participants taking part in the ceremonial first dig l (from left: LOTTE BIOLOGICS Chief Global Strategy Officer Yoo-Yeol Shin, Incheon Yeonsu District Mayor Jae-Ho Lee, LOTTE E&C CEO Hyeon-Cheol Park, LOTTE Corporation CEO Dong-Woo Lee, National Assembly Member Il-Young Jung, LOTTE Chairman Dong-Bin Shin, Incheon Mayor Jeong-Bok Yoo, First Vice Minister of Trade, Industry and Energy Kyung-Sung Kang, Second Vice Minister of Health and Welfare Min-Soo Park, LOTTE BIOLOGICS CEO Richard W. Lee, Incheon Free Economic Zone Commissioner Won-Seok Yoon, and LOTTE Holdings Japan CEO Genichi Tamatsuka)
      Groundbreaking ceremony participants taking part in the ceremonial first dig l (from left: LOTTE BIOLOGICS Chief Global Strategy Officer Yoo-Yeol Shin, Incheon Yeonsu District Mayor Jae-Ho Lee, LOTTE E&C CEO Hyeon-Cheol Park, LOTTE Corporation CEO Dong-Woo Lee, National Assembly Member Il-Young Jung, LOTTE Chairman Dong-Bin Shin, Incheon Mayor Jeong-Bok Yoo, First Vice Minister of Trade, Industry and Energy Kyung-Sung Kang, Second Vice Minister of Health and Welfare Min-Soo Park, LOTTE BIOLOGICS CEO Richard W. Lee, Incheon Free Economic Zone Commissioner Won-Seok Yoon, and LOTTE Holdings Japan CEO Genichi Tamatsuka)
      Groundbreaking ceremony participants taking part in the ceremonial first dig l (from left: LOTTE BIOLOGICS Chief Global Strategy Officer Yoo-Yeol Shin, Incheon Yeonsu District Mayor Jae-Ho Lee, LOTTE E&C CEO Hyeon-Cheol Park, LOTTE Corporation CEO Dong-Woo Lee, National Assembly Member Il-Young Jung, LOTTE Chairman Dong-Bin Shin, Incheon Mayor Jeong-Bok Yoo, First Vice Minister of Trade, Industry and Energy Kyung-Sung Kang, Second Vice Minister of Health and Welfare Min-Soo Park, LOTTE BIOLOGICS CEO Richard W. Lee, Incheon Free Economic Zone Commissioner Won-Seok Yoon, and LOTTE Holdings Japan CEO Genichi Tamatsuka)
      LOTTE Group Chairman Dong-Bin Shin delivering the welcome address at the groundbreaking ceremony
      LOTTE Group Chairman Dong-Bin Shin delivering the welcome address at the groundbreaking ceremony
      LOTTE BIOLOGICS CEO Richard W. Lee giving a speech at the groundbreaking ceremony
      LOTTE BIOLOGICS CEO Richard W. Lee giving a speech at the groundbreaking ceremony

      Pri tejto slávnostnej príležitosti sa zišlo okolo 300 vážených hostí, medzi ktorými boli predseda LOTTE Group Dong-Bin Shin, starosta mesta Incheon Jeong-Bok Yoo, člen Národného zhromaždenia Il-Young Jung v zastúpení okresu Incheon Yeonsu, prvý námestník ministra obchodu, priemyslu a energetiky Kyung-Sung Kang, druhý námestník ministra zdravotníctva a sociálnych vecí Min-Soo Park a komisár slobodnej ekonomickej zóny Incheon Won-Seok Yoon. Svoju gratuláciu vyjadril aj premiér Duck-Soo Han prostredníctvom video odkazu.

      LOTTE Group aktuálne rozširuje svoje podnikanie zamerané na štyri témy: „Bio & Wellness", „Mobilita", „Udržateľnosť" a „Nové platformy pre život". Areál Songdo Bio Campus, základný kameň sektora Bio & Wellness, predstavuje investíciu približne 4,6 bilióna wonov. Toto špičkové zariadenie s rozlohou pôsobivých 202 285,2 metrov štvorcových má obsahovať tri špičkové výrobné závody doplnené základnými pomocnými budovami.

      Spoločnosť LOTTE Engineering & Construction bude viesť návrh, obstarávanie a výstavbu prvého závodu, pričom bude prezentovať integrovaný prístup skupiny k tomuto transformačnému projektu. Plánuje sa, že každý závod bude mať výrobnú kapacitu 120 000 litrov, čo predstavuje v celom areáli celkovo 360 000 litrov. Rozsah tohto úsilia ďalej zdôrazňuje jeho plánovaný ekonomický vplyv vo výške 7,6 bilióna wonov a vytvorenie 37 000 súvisiacich pracovných miest, čo ilustruje záväzok spoločnosti LOTTE BIOLOGIC k priemyselnému pokroku a sociálno-ekonomickému rastu.

      Predseda LOTTE, Dong-Bin Shin, na stretnutí vyjadril víziu, ktorá presahuje firemný rast: „Cesta spoločnosti LOTTE BIOLOGICS, ktorá sa začína tu v Songdo, je pripravená stať sa nielen budúcim motorom rastu pre skupinu LOTTE, ale aj pretvoriť prostredie odvetvia kórejskej biotechnológie. Neustále sa snažíme výrazne prispievať k úspešnému založeniu bioklastra Songdo, čím sa Kórea posunie do popredia globálnej biotechnologickej arény."

      Tento postoj ešte zopakoval a umocnil premiér Duck-Soo Han vo svojom video príhovore. S vedomím silnejúcej globálnej konkurencie na biotechnologickom trhu uviedol: „Očakáva sa, že odvážna investícia skupiny LOTTE výrazne zvýši konkurencieschopnosť kórejského biofarmaceutického priemyslu." Predseda vlády ďalej načrtol podporný postoj vlády a zaviazal sa „aktívne napomáhať investíciám súkromného sektora v hodnote 36,3 bilióna wonov, plánovaným do roku 2040, ktoré sú sústredené okolo nedávno určeného komplexu špecializovaného národného pokročilého strategického priemyslu pre biotechnológie".

      Generálny riaditeľ LOTTE BIOLOGICS Richard W. Lee vo svojom príhovore ponúkol svoj vlastný pohľad: „Rád by som vyjadril úprimnú vďaku vládnym agentúram a inštitucionálnym predstaviteľom, ktorí nám poskytli neoceniteľnú podporu pri účasti na tejto významnej príležitosti." Následne predstavil ambicióznu trajektóriu spoločnosti a vyhlásil: „LOTTE BIOLOGICS sa zaviazala zaradiť sa medzi globálnych TOP 10 bio-CDMO spoločností do roku 2030. Prostredníctvom tohto rastu sa snažíme slúžiť ako hnacia sila, ktorá posunie Kóreu do popredia globálnej bioekonomiky, čím sa naša krajina stane v tomto kritickom sektore vedúcou silou."

      O spoločnosti LOTTE BIOLOGICS

      Spoločnosť LOTTE BIOLOGICS bola založená v roku 2022 a sídli v juhokórejskom Soule. Spoločnosť LOTTE BIOLOGICS vstúpila do farmaceutického priemyslu ako spoločnosť CDMO akvizíciou výrobného závodu biologics Syracuse spoločnosti Bristol Myers Squibb.

      Závod v Syrakúzach ponúka služby výroby liečivých látok s celkovou kapacitou 35 000 l výrobného bioreaktora (7 x 5 000 l bioreaktorov) s využitím bioreaktorov z nehrdzavejúcej ocele, analytických laboratórií na testovanie kontroly kvality a skladových zariadení. Pracovisko je plne funkčné podľa GMP s klinickými a komerčnými funkciami. K dnešnému dňu získalo pracovisko viac ako 60 schválení na celom svete od FDA, EMA, PMDA a MFDS. Okrem toho je spoločnosť strategicky pripravená vytvoriť komplexnú všestrannú platformu na pre služby CDMO, ktorá do svojho obchodného portfólia začlení služby konjugátov protilátok (ADC) a liekových produktov (DP) prostredníctvom rozšírenia zariadenia.

      Do roku 2030 plánuje LOTTE BIOLOGICS postaviť 3 veľké závody v Južnej Kórei. Každý závod bude mať 8 bioreaktorov z nehrdzavejúcej ocele s kapacitou 15 000 l pre veľké komerčné prevádzky spolu s viacerými 2 000 l bioreaktormi na jedno použitie, aby vyhovovali klinickým potrebám. Začiatok výstavby sa očakáva v roku 2023. Dohromady budú mať závody celkový výrobný objem v kapacite bioreaktora minimálne 360 000 l.

      Viac informácií o LOTTE BIOLOGICS nájdete na stránke: www.lottebiologics.com 

      Foto: https://mma.prnewswire.com/media/2454113/Groundbreaking_ceremony_participants_part_ceremonial_dig.jpg
      Foto: https://mma.prnewswire.com/media/2454114/Groundbreaking_ceremony_participants_part_ceremonial_dig_l.jpg
      Foto: https://mma.prnewswire.com/media/2454115/1.jpg
      Foto: https://mma.prnewswire.com/media/2454116/2.jpg
      Logo: https://mma.prnewswire.com/media/2197419/CI_Logo.jpg

      Modal title

      Also from this source

      LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

      LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use

      LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio Campus in Incheon,...

      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

      LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma

      LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company...

      More Releases From This Source

      Explore

      General Manufacturing

      General Manufacturing

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.